These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36949579)

  • 1. Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
    Eichenfield LF; Stein Gold L; Kircik LH; Werschler WP; Beer K; Draelos ZD; Tanghetti EA; Papp KA; Baldwin H; Lain E; Sadick N; Gooderham MJ; Konda A
    Pediatr Dermatol; 2023; 40(3):452-459. PubMed ID: 36949579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
    Stein Gold L; Baldwin H; Kircik LH; Weiss JS; Pariser DM; Callender V; Lain E; Gold M; Beer K; Draelos Z; Sadick N; Pillai R; Bhatt V; Tanghetti EA
    Am J Clin Dermatol; 2022 Jan; 23(1):93-104. PubMed ID: 34674160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric Participants.
    Baldwin H; Gold LS; Harper JC; Alexis AF; Callender VD; Kircik L; Guenin E; Eichenfield LF
    J Drugs Dermatol; 2024 Jun; 23(6):394-402. PubMed ID: 38834226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Male and Female Acne: Phase 3 Analysis.
    Lain ET; Bhatia N; Kircik L; Gold LS; Harper JC; Bunick CG; Guenin E; Baldwin H; Feldman SR; Rosso JQD
    J Drugs Dermatol; 2024 Oct; 23(10):873-881. PubMed ID: 39361705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
    Keating GM
    Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
    Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
    J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials.
    Draelos ZD; Tanghetti EA; Kircik LH; Bhatia N; Zeichner JA; Sugarman JL; Stein Gold L
    J Dermatolog Treat; 2023 Dec; 34(1):2220446. PubMed ID: 37341243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
    Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
    J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
    Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
    J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
    Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
    Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
    Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel.
    Eichenfield LF; Krakowski AC
    J Drugs Dermatol; 2012 Jul; 11(7):818-24. PubMed ID: 22777222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
    Stein Gold L; Lain E; Del Rosso JQ; Gold M; Draelos ZD; Eichenfield LF; Sadick N; Werschler WP; Gooderham MJ; Lupo M
    J Am Acad Dermatol; 2023 Nov; 89(5):927-935. PubMed ID: 37656094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
    Gold LS
    Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations.
    Stein Gold L
    J Drugs Dermatol; 2015 Sep; 14(9):969-74. PubMed ID: 26355615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
    Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
    J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.